BUSINESS

• Takeda Gets China OK for Shire Takeover
  September 18, 2018

• Sekisui Chemical Hooks Up with Regenerative Medicine Upstart
  September 14, 2018

• Shionogi Grabs Rights to Rohto’s Cell-Based Hepatic Cirrhosis Therapy
  September 14, 2018

• Poxel Forms Japan Outpost, Hitches Janssen’s Kaneko as Country Chief
  September 14, 2018

• I/O in Lung Cancer - 5: Roche Looks Beyond Tecentriq, Laying Foundation for Next-Gen Immunotherapies
  September 13, 2018

• Ex-AZ Exec Nogami Tapped to Lead Takeda Consumer Healthcare
  September 13, 2018

• Kowa Continues Heavy GP Pitch for Parmodia in July: Anterio
  September 13, 2018

• Nippon Shinyaku Eyes Conditional Early OK for Sakigake DMD Drug, Daiichi Sankyo Redoing PI/II for Its Antisense
  September 12, 2018

• Quizartinib Earns Japan Orphan Status for AML: Daiichi Sankyo
  September 12, 2018

• Avastin Best-Selling Drug in Japan in August: Encise Snapshot
  September 12, 2018

• Risankizumab Hits Primary Endpoint in Japan PII/III Study with Psoriasis Vulgaris Patients: AbbVie
  September 11, 2018

• Power Back On at Drug Makers’ Hokkaido Plants
  September 11, 2018

• Tremfya Meets Primary Endpoint in Japan PIII Study for Palmoplantar Pustulosis: Janssen
  September 11, 2018

• Ethical Drug Sales Up 3.6% in July: Crecon
  September 11, 2018

• Shionogi Loses HIV Patent Battle against MSD
  September 10, 2018

• Hokkaido Quake Hits Wholesaler Price Negotiations as Sept. Deadline for Medical Fee Cuts Looms
  September 10, 2018

• Sanofi to Focus on Increasing Prescriptions of Lantus XR Based on Results of Head-to-Head Comparison Study
  September 10, 2018

• Xofluza Cuts Flu Symptoms, Vial Loads: Shionogi
  September 7, 2018

• Ono to Divide Oncology Sales Force into Two Units as Opdivo Label Expands
  September 7, 2018

• Giant Quake Disrupts Drug Production, Shipments in Hokkaido; Distributors Scramble to Ensure Supplies
  September 7, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 381
• 382
• 383
• 384
• 385
• 386
• 387
• 388
• 389
• …
• Next ›
• 最終 »